TEAS RF New Application

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88251756

Filing Date: 01/07/2019

To the Commissioner for Trademarks:

MARK: ALFATROL (Standard Characters, see mark)
The literal element of the mark consists of ALFATROL.
The mark consists of standard characters, without claim to any particular font style, size, or color.

The applicant, ISHIHARA SANGYO KAISHA, LTD., a corporation of Japan, having an address of
      3-15, Edobori 1-chome, Nishi-ku,
      Osaka 550-0002
      Japan
      XXXX (not authorized)

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 005:  Pharmaceutical preparations for the treatment of Anti-inflammatory, anti-shock, inflammation of digestive system, inflammation of respiratory system, anti-pancreatitis, pulmonary insufficiency, kidney disease, disseminated intravascular coagulation, chronic obstructive pulmonary disease, pyometra, spondylosis deformans, systemic inflammatory response syndrome, pneumonia, infectious peritonitis, sepsis, inhibiting thrombogenesis, allergy, tumor metastasis control, infectious disease, encephalitis and surgical stress; veterinary preparations for Companion animals, farm animals, dogs, cats, horses, chickens, cattle and pigs for the treatment of Anti-inflammatory, anti-shock, inflammation of digestive system, inflammation of respiratory system, anti-pancreatitis, pulmonary insufficiency, kidney disease, disseminated intravascular coagulation, chronic obstructive pulmonary disease, pyometra, spondylosis deformans, systemic inflammatory response syndrome, pneumonia, infectious peritonitis, sepsis, inhibiting thrombogenesis, allergy, tumor metastasis control, infectious disease, encephalitis and surgical stress; pharmaceutical agents affecting digestive organs; pharmaceutical preparations for skin care for animals; medicines for veterinary purposes for Companion animals, farm animals, dogs, cats, horses, chickens, cattle and pigs for the treatment of Anti-inflammatory, anti-shock, inflammation of digestive system, inflammation of respiratory system, anti-pancreatitis, pulmonary insufficiency, kidney disease, disseminated intravascular coagulation, chronic obstructive pulmonary disease, pyometra, spondylosis deformans, systemic inflammatory response syndrome, pneumonia, infectious peritonitis, sepsis, inhibiting thrombogenesis, allergy, tumor metastasis control, infectious disease, encephalitis and surgical stress.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.


The applicant's current Attorney Information:
      Joseph S. Presta and all other attorneys at Nixon & Vanderhye, PC of Nixon & Vanderhye, PC
      11th Floor
      901 N. Glebe Rd.
      Arlington, Virginia 22203
      United States
      703-816-4000 x4042(phone)
      703-816-4100(fax)
      nixonptomail@nixonvan.com (authorized)
The attorney docket/reference number is 1035-1386.

The applicant hereby appoints Joseph S. Presta of Nixon & Vanderhye, PC
      11th Floor
      901 N. Glebe Rd.
      Arlington Virginia 22203
      United States
      703-816-4000 x4042(phone)
      703-816-4100(fax)
      nixonptomail@nixonvan.com (authorized)
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.

The applicant's current Correspondence Information:

Joseph S. Presta

Nixon & Vanderhye, PC

11th Floor       901 N. Glebe Rd.

Arlington, Virginia 22203

703-816-4000 x4042(phone)

703-816-4100(fax)

nixonptomail@nixonvan.com;jsp@nixonvan.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /Joseph S. Presta/   Date: 01/07/2019
Signatory's Name: Joseph S. Presta
Signatory's Position: Attorney for Applicant, VA bar member
Payment Sale Number: 88251756
Payment Accounting Date: 01/07/2019

Serial Number: 88251756
Internet Transmission Date: Mon Jan 07 11:05:40 EST 2019
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XXX-201901071105403
51683-88251756-62013d7755aa9a9c9d5c2e7ce
8bd91345e78a36ca605c37e69b2dedf85da5b79a
-CC-9801-20190107110342537850